Our investigation suggests that CA-125, remarkably predicts intraocular metastases in postmenopausal breast cancer as risk factors, and the combination of CA-125 and CA 15-3 shows considerable diagnostic value. The gene discussed is MUC16; the disease is breast carcinoma.